(Q40551797)

21 September 2017

Hematopoietic stem cell transplantation for severe Crohn's disease (English)

1 reference

21 September 2017

Craig RM

1

1 reference

21 September 2017

Traynor A

series ordinal

2

1 reference

21 September 2017

Oyama Y

series ordinal

3

1 reference

21 September 2017

Burt RK

series ordinal

4

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Bone Marrow Transplantation

21 September 2017

1 reference

21 September 2017

32 Suppl 1

1 reference

21 September 2017

S57-9

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703945

21 September 2017

0 references

cites work

A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

Autologous bone marrow transplantation for non-Hodgkin's lymphoma resulting in long-term remission of coincidental Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulphasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

7 January 2021

Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

7 January 2021

Controlled trial of azathioprine in Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

7 January 2021

Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

7 January 2021

A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

7 January 2021

Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

7 January 2021

Clinical course of colorectal Crohn's disease: a 35-year follow-up study of 507 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

7 January 2021

Course of Crohn's disease after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

7 January 2021

Case of Crohn's disease in bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703945

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703945

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference